{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:56:34Z","timestamp":1772931394220,"version":"3.50.1"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.semdp.2025.150948","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:48:03Z","timestamp":1754441283000},"page":"150948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Histopathological and genetic landscape of pancreatic ductal adenocarcinoma and its variants"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-0714","authenticated-orcid":false,"given":"Nicholas J.","family":"Caldwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8029-4787","authenticated-orcid":false,"given":"M. Lisa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0003","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0004","first-page":"10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41575-023-00856-2","article-title":"Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer","volume":"21","author":"Stoop","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10242","key":"10.1016\/j.semdp.2025.150948_bib0007","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.semdp.2025.150948_bib0008","unstructured":"Burgart, L.J., W.V. Chopp, and D. Jain College of American Pathologists protocol for the examination of specimens from patients with carcinoma of the pancreas. 2021."},{"key":"10.1016\/j.semdp.2025.150948_bib0009","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2018"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/his.14067","article-title":"Microscopic size measurements in post-neoadjuvant therapy resections of pancreatic ductal adenocarcinoma (PDAC) predict patient outcomes","volume":"77","author":"Zhang","year":"2020","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.semdp.2025.150948_bib0011","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/PAS.0000000000000887","article-title":"Prognostic significance of new AJCC tumor stage in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy","volume":"41","author":"Chatterjee","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/cco-21-175","article-title":"Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review","volume":"11","author":"Taherian","year":"2022","journal-title":"Chin Clin Oncol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0013","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/PAS.0000000000001853","article-title":"Pathologic examination of pancreatic specimens resected for treated pancreatic ductal adenocarcinoma: recommendations from the pancreatobiliary pathology society","volume":"46","author":"Wang","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0014","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/his.15199","article-title":"Evaluation of fine-needle core biopsy specimens for pancreatic ductal adenocarcinoma: diagnostic utility and helpful histological features","volume":"85","author":"Gonzalez","year":"2024","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.path.2022.05.001","article-title":"The diagnostic challenge of evaluating small biopsies from the pancreatobiliary system","volume":"15","author":"Thompson","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.semdp.2025.150948_bib0016","volume":"1","year":"2019"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.semdp.2014.08.004","article-title":"Adenocarcinoma of the pancreas","volume":"31","author":"Hruban","year":"2014","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0018","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-200004000-00003","article-title":"Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant","volume":"24","author":"Adsay","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0019","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41379-021-00902-x","article-title":"Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis","volume":"35","author":"Muraki","year":"2022","journal-title":"Mod Pathol"},{"issue":"23","key":"10.1016\/j.semdp.2025.150948_bib0020","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.3748\/wjg.v27.i23.3262","article-title":"Large-duct pattern invasive adenocarcinoma of the pancreas-a variant mimicking pancreatic cystic neoplasms: a mini review","volume":"27","author":"Sato","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/modpathol.2011.181","article-title":"Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia","volume":"25","author":"Bagci","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0022","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/PAS.0b013e318249ce1c","article-title":"Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma","volume":"36","author":"Kelly","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.semdp.2025.150948_bib0023","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1136\/gut.2010.232272","article-title":"Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes","volume":"60","author":"Mino-Kenudson","year":"2011","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0024","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1097\/MPA.0000000000002326","article-title":"Clinical relevance of cancerization of ducts in resected pancreatic ductal adenocarcinoma","volume":"53","author":"Kinny-K\u00f6ster","year":"2024","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.semdp.2025.150948_bib0025","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/s41379-020-0572-6","article-title":"Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy","volume":"33","author":"Fujikura","year":"2020","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0026","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pan.2015.09.017","article-title":"Surgical and oncological impact of main pancreatic duct spread in invasive ductal adenocarcinoma: a clinicopathological study of 184 resected cases","volume":"15","author":"Ishii","year":"2015","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0027","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000065089","article-title":"Intraductal spread of pancreatic cancer. Clinicopathologic study of 54 pancreatectomized patients","volume":"2","author":"Yamasaki","year":"2002","journal-title":"Pancreatology"},{"issue":"12","key":"10.1016\/j.semdp.2025.150948_bib0028","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0029","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jclinpath-2016-203604","article-title":"The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes","volume":"69","author":"Kalimuthu","year":"2016","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150948_bib0030","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.5858\/133.10.1539","article-title":"Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum","volume":"133","author":"Washington","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.semdp.2025.150948_bib0031","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archsurg.1992.01420110083017","article-title":"Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas","volume":"127","author":"Evans","year":"1992","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0032","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAS.0000000000001601","article-title":"A critical assessment of postneoadjuvant therapy pancreatic cancer regression grading schemes with a proposal for a novel approach","volume":"45","author":"Chou","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74067-z","article-title":"Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems","volume":"10","author":"Matsuda","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.semdp.2025.150948_bib0034","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/cncr.26651","article-title":"Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome","volume":"118","author":"Chatterjee","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jclinpath-2016-203947","article-title":"Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study","volume":"70","author":"Kalimuthu","year":"2017","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0036","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41379-020-00683-9","article-title":"Amsterdam international consensus meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy","volume":"34","author":"Janssen","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0037","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10.1016\/j.semdp.2025.150948_bib0038","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/modpathol.2016.98","article-title":"The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes","volume":"29","author":"Basturk","year":"2016","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0039","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPA.0000000000000253","article-title":"Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas","volume":"44","author":"Kuboki","year":"2015","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0002-9440(10)64589-0","article-title":"Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas","volume":"157","author":"Iacobuzio-Donahue","year":"2000","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150948_bib0041","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/00000478-200011000-00011","article-title":"Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression","volume":"24","author":"Iacobuzio-Donahue","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0042","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jasc.2018.07.002","article-title":"Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma","volume":"7","author":"Sweeney","year":"2018","journal-title":"J Am Soc Cytopathol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150948_bib0043","first-page":"2002","article-title":"Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression","volume":"60","author":"Wilentz","year":"2000","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0044","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/his.13894","article-title":"Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas","volume":"75","author":"Ritterhouse","year":"2019","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0045","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/jhbp.1286","article-title":"P53 immunolabeling in EUS-FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy","volume":"30","author":"Oshima","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"20","key":"10.1016\/j.semdp.2025.150948_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11206097","article-title":"Usefulness of adding maspin staining to p53 staining for EUS-FNA specimens of pancreatic ductal adenocarcinoma","volume":"11","author":"Fukushi","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0047","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pan.2017.12.010","article-title":"Immunohistochemical analysis of IMP3 and p53 expression in endoscopic ultrasound-guided fine needle aspiration and resected specimens of pancreatic diseases","volume":"18","author":"Senoo","year":"2018","journal-title":"Pancreatology"},{"issue":"7","key":"10.1016\/j.semdp.2025.150948_bib0048","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.ajpath.2018.03.012","article-title":"Genome-wide somatic copy number alterations and mutations in high-grade pancreatic intraepithelial neoplasia","volume":"188","author":"Hata","year":"2018","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0049","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4884","article-title":"Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4","volume":"242","author":"Hosoda","year":"2017","journal-title":"J Pathol"},{"issue":"15","key":"10.1016\/j.semdp.2025.150948_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153765","article-title":"SMAD4 positive pancreatic ductal adenocarcinomas are associated with better outcomes in patients receiving FOLFIRINOX-based neoadjuvant therapy","volume":"15","author":"Racu","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152925","article-title":"Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma","volume":"216","author":"Hedegaard Jensen","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0052","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3420","article-title":"Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma","volume":"4","author":"Qian","year":"2018","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150948_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071205","article-title":"Deficiency of MTAP is frequent and mostly homogeneous in pancreatic ductal adenocarcinomas","volume":"17","author":"Gorbokon","year":"2025","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0054","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncy.22777","article-title":"The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens","volume":"132","author":"Yu","year":"2024","journal-title":"Cancer Cytopathol"},{"issue":"7","key":"10.1016\/j.semdp.2025.150948_bib0055","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/modpathol.3800377","article-title":"Concordant loss of MTAP and p16\/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion","volume":"18","author":"Hustinx","year":"2005","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150948_bib0056","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/PAS.0000000000002297","article-title":"Prevalence of S-methyl-5\u2032-thioadenosine phosphorylase (MTAP) deficiency in Human cancer: a tissue microarray study on 13,067 tumors from 149 different tumor types","volume":"48","author":"Gorbokon","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semdp.2025.150948_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152356","article-title":"Evaluation of the diagnostic utility of NCOA3, Maspin and VHL protein expression in pancreatic ductal adenocarcinoma: an immunohistochemical study","volume":"73","author":"Elkady","year":"2024","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150948_bib0058","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/MPA.0000000000002188","article-title":"Role of immunohistochemistry in suspected pancreatic ductal adenocarcinoma: a prospective study on fine needle aspiration biopsies","volume":"51","author":"Valentini","year":"2022","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.semdp.2025.150948_bib0059","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.31557\/APJCP.2021.22.10.3299","article-title":"Role of maspin, CK17 and Ki-67 immunophenotyping in diagnosing of pancreatic ductal adenocarcinoma in endoscopic ultrasound-guided fine needle aspiration cytology","volume":"22","author":"Mamdouh","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0060","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MPA.0000000000000774","article-title":"Immunohistochemical antibody panel for the differential diagnosis of pancreatic ductal carcinoma from gastrointestinal contamination and benign pancreatic duct epithelium in endoscopic ultrasound-guided fine-needle aspiration","volume":"46","author":"Furuhata","year":"2017","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0061","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pin.12505","article-title":"Double immunostaining for maspin and p53 on cell blocks increases the diagnostic value of biliary brushing cytology","volume":"67","author":"Kanzawa","year":"2017","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0062","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cyt.12368","article-title":"Immunocytochemistry for Claudin-18 and Maspin in biliary brushing cytology increases the accuracy of diagnosing pancreatobiliary malignancies","volume":"28","author":"Tokumitsu","year":"2017","journal-title":"Cytopathology"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0063","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.humpath.2013.10.004","article-title":"Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma","volume":"45","author":"Lok","year":"2014","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0064","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2001-1326-2-8","article-title":"Role of maspin in cancer","volume":"2","author":"Berardi","year":"2013","journal-title":"Clin Transl Med"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5858\/arpa.2011-0326-OA","article-title":"Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas","volume":"136","author":"Liu","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.semdp.2025.150948_bib0066","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.cgh.2008.08.010","article-title":"Immunostaining as an adjunct to cytology for diagnosis of pancreatic adenocarcinoma","volume":"6","author":"Agarwal","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0067","first-page":"86","article-title":"Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas","volume":"7","author":"Kashima","year":"2008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0068","doi-asserted-by":"crossref","first-page":"556","DOI":"10.5858\/2007-131-556-DISWPI","article-title":"Double immunohistochemical staining with MUC4\/p53 is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray-based study","volume":"131","author":"Bhardwaj","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0069","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.3800772","article-title":"Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases","volume":"20","author":"Cao","year":"2007","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.pai.0000203037.25791.21","article-title":"Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study","volume":"15","author":"Nash","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0071","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00129039-200203000-00011","article-title":"Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis","volume":"10","author":"Oh","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0072","first-page":"812","article-title":"Expression of the tumor suppressor gene Maspin in human pancreatic cancers","volume":"7","author":"Maass","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040397","article-title":"Mesothelin expression in Human tumors: a tissue microarray study on 12,679 tumors","volume":"9","author":"Weidemann","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.semdp.2025.150948_bib0074","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/07357907.2021.1943747","article-title":"Mesothelin is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness","volume":"39","author":"Weidemann","year":"2021","journal-title":"Cancer Invest"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejso.2018.10.050","article-title":"Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: a multi-institutional cohort study","volume":"45","author":"Nahm","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"16","key":"10.1016\/j.semdp.2025.150948_bib0076","doi-asserted-by":"crossref","first-page":"26744","DOI":"10.18632\/oncotarget.15814","article-title":"Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma","volume":"8","author":"Inaguma","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0077","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00428-016-2014-x","article-title":"Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas","volume":"469","author":"Basturk","year":"2016","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0078","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.prp.2016.01.007","article-title":"Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis","volume":"212","author":"Ibrahim","year":"2016","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0079","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3892\/ol.2015.2969","article-title":"Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms","volume":"9","author":"Einama","year":"2015","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1309\/AJCPDTTL2I5ECMFG","article-title":"Mesothelin expression in pancreatic mucinous cysts","volume":"142","author":"Frank","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0081","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/dc.21684","article-title":"The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration","volume":"42","author":"Dim","year":"2011","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0082","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/1066896911409575","article-title":"Mesothelin and GPR30 staining among a spectrum of pancreatic epithelial neoplasms","volume":"19","author":"Glass","year":"2011","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0083","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1309\/CEV30BE088CBDQD9","article-title":"Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates","volume":"126","author":"Jhala","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0084","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/F1B64CL7H8VJKEAF","article-title":"Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis","volume":"124","author":"Hassan","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.semdp.2025.150948_bib0085","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.MP.0000086072.56290.FB","article-title":"Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray","volume":"16","author":"Maitra","year":"2003","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0086","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.pan.2024.04.005","article-title":"K-ras mutation detected by peptide nucleic acid-clamping polymerase chain reaction, Ki-67, S100P, and SMAD4 expression can improve the diagnostic accuracy of inconclusive pancreatic EUS-FNB specimens","volume":"24","author":"Kim","year":"2024","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0087","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/JOC.JOC_18_17","article-title":"Diagnostic value of S100p, IMP3, maspin, and pVHL in the differantial diagnosis of pancreatic ductal adenocarcinoma and normal\/chronic pancreatitis in fine needle aspiration biopsy","volume":"35","author":"Aksoy-Altinboga","year":"2018","journal-title":"J Cytol"},{"key":"10.1016\/j.semdp.2025.150948_bib0088","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1472-6890-14-35","article-title":"Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel","volume":"14","author":"Ali","year":"2014","journal-title":"BMC Clin Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0089","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.pan.2019.08.007","article-title":"Design of an immunohistochemistry biomarker panel for diagnosis of pancreatic adenocarcinoma","volume":"19","author":"Burnett","year":"2019","journal-title":"Pancreatology"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jasc.2015.10.003","article-title":"A study to improve the identification of pancreatobiliary adenocarcinoma utilizing fine-needle aspiration cytology and immunohistochemical application for KOC and S100P","volume":"5","author":"Tinsley","year":"2016","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.semdp.2025.150948_bib0091","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/678260","article-title":"Histological characterization of biliary intraepithelial neoplasia with respect to pancreatic intraepithelial neoplasia","volume":"2014","author":"Sato","year":"2014","journal-title":"Int J Hepatol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0092","first-page":"109","article-title":"Expression of von Hippel-Lindau gene product (pVHL) and S100P in cystic neoplasms of the pancreas\u2013with an implication for their roles in tumorigenesis","volume":"42","author":"Liu","year":"2012","journal-title":"Ann Clin Lab Sci"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0093","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.humpath.2009.11.007","article-title":"S100P is a novel marker to identify intraductal papillary mucinous neoplasms","volume":"41","author":"Nakata","year":"2010","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0094","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1309\/5D76NDE81LE8G545","article-title":"Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens","volume":"129","author":"Deng","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/PAS.0b013e31815701d1","article-title":"Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis","volume":"32","author":"Lin","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0096","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.pas.0000213438.01278.5f","article-title":"Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray","volume":"31","author":"Higgins","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0097","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12029-021-00770-3","article-title":"A promising diagnostic role of immunohistochemical expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in pancreatic lesions using endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology","volume":"54","author":"Rashed","year":"2023","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0098","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96492-4","article-title":"Diagnostic value of IMP3 and p53 immunohistochemical staining in EUS-guided fine-needle aspiration for solid pancreatic tumors","volume":"11","author":"Mikata","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0099","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MEG.0000000000001696","article-title":"Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma","volume":"32","author":"Tadic","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0100","first-page":"3","article-title":"IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: a tissue microarray study on 8,877 human cancers and normal tissues","volume":"39","author":"Burdelski","year":"2018","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jnci.2016.10.002","article-title":"The role of S100P and IMP3 in the cytologic diagnosis of pancreatic adenocarcinoma","volume":"28","author":"Ezzat","year":"2016","journal-title":"J Egypt Natl Canc Inst"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0102","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12094-014-1216-4","article-title":"Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions","volume":"17","author":"Wang","year":"2015","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"10.1016\/j.semdp.2025.150948_bib0103","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.humpath.2012.12.020","article-title":"Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm","volume":"44","author":"Morimatsu","year":"2013","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0104","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/PAS.0b013e3182189223","article-title":"Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma","volume":"35","author":"Wachter","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000325470","article-title":"Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas","volume":"52","author":"Yantiss","year":"2008","journal-title":"Acta Cytol"},{"key":"10.1016\/j.semdp.2025.150948_bib0106","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2147\/OTT.S128810","article-title":"Prognostic value of high IMP3 expression in solid tumors: a meta-analysis","volume":"10","author":"Chen","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0107","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/Q0FLUXFJ4FTTW1XR","article-title":"Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus","volume":"129","author":"Lin","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0108","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00423-024-03506-6","article-title":"Histological variants of pancreatic ductal adenocarcinoma: a survival analysis","volume":"409","author":"Bengtsson","year":"2024","journal-title":"Langenbecks Arch Surg"},{"issue":"11","key":"10.1016\/j.semdp.2025.150948_bib0109","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00535-022-01920-5","article-title":"The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry","volume":"57","author":"Satake","year":"2022","journal-title":"J Gastroenterol"},{"issue":"16","key":"10.1016\/j.semdp.2025.150948_bib0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163946","article-title":"Clinical outcome and prognostic factors of pancreatic adenosquamous carcinoma compared to ductal adenocarcinoma-results from the german Cancer Registry group","volume":"14","author":"Braun","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.semdp.2025.150948_bib0111","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ejso.2021.02.011","article-title":"Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - matched-pair analysis with pancreatic ductal adenocarcinoma","volume":"47","author":"Kaiser","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0112","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2009.07.012","article-title":"Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients","volume":"41","author":"Voong","year":"2010","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0113","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12029-017-9982-1","article-title":"Primary squamous cell carcinoma of the pancreas: a case report and literature review","volume":"50","author":"Alajlan","year":"2019","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0114","first-page":"144","article-title":"Metastatic squamous cell carcinoma to the pancreas: report of an extremely rare case","volume":"10","author":"Machairas","year":"2019","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1245\/s10434-016-5619-z","article-title":"Long-term outcomes of 98 surgically resected metastatic tumors in the pancreas","volume":"24","author":"Lee","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150948_bib0116","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/01.MP.0000028647.98725.8B","article-title":"The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis","volume":"15","author":"Adsay","year":"2002","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0117","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000478-200201000-00006","article-title":"Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases","volume":"26","author":"Seidel","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0118","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00000478-200305000-00002","volume":"27","author":"Adsay","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0119","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/SLA.0b013e318214bcb4","article-title":"Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma","volume":"253","author":"Yopp","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0120","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/MPA.0000000000002227","article-title":"Survival and prognostic factors in patients with pancreatic colloid carcinoma compared with pancreatic ductal adenocarcinoma","volume":"52","author":"Khalil","year":"2023","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0121","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/MPA.0000000000001787","article-title":"The role of perioperative chemotherapy in the management of colloid carcinoma of the pancreas","volume":"50","author":"Picado","year":"2021","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0122","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/PAS.0b013e3181861bcd","article-title":"Mucus rupture (extrusion) and duct expansion\/expansive growth are not diagnostic of minimal invasion when seen with intraductal papillary mucinous neoplasms","volume":"33","author":"Stelow","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0123","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","article-title":"Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas","volume":"38","author":"Moncada","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150948_bib0124","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semdp.2025.150948_bib0126","series-title":"Tumors of the Pancreas. AFIP Atlases of Tumor and Non-Tumor Pathology","author":"Klimstra","year":"2023"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0127","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7592","key":"10.1016\/j.semdp.2025.150948_bib0128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semdp.2025.150948_bib0129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","article-title":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","volume":"6","author":"Roberts","year":"2016","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0130","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gutjnl-2020-323611","article-title":"Long-term yield of pancreatic cancer surveillance in high-risk individuals","volume":"71","author":"Overbeek","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"issue":"22","key":"10.1016\/j.semdp.2025.150948_bib0132","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1158\/1078-0432.CCR-22-3930","article-title":"Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer","volume":"29","author":"Singh","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.semdp.2025.150948_bib0133","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-21-3581","article-title":"Molecular characterization of KRAS wild-type tumors in patients with pancreatic adenocarcinoma","volume":"28","author":"Philip","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C-mutated advanced pancreatic cancer","volume":"388","author":"Strickler","year":"2023","journal-title":"N Engl J Med"},{"issue":"4_suppl","key":"10.1016\/j.semdp.2025.150948_bib0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1200\/JCO.2022.40.4_suppl.519","article-title":"KRYSTAL-1: updated activity and safety of adagrasib (MRTX849) in patients (Pts) with unresectable or metastatic pancreatic cancer (PDAC) and other gastrointestinal (GI) tumors harboring a KRAS G12C mutation","volume":"40","author":"Bekaii-Saab","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semdp.2025.150948_bib0136","article-title":"Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma","volume":"13","author":"Kumar","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150948_bib0137","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/bjc.2012.18","article-title":"Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer","volume":"106","author":"Harder","year":"2012","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0138","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jclinpath-2021-207781","article-title":"Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature","volume":"76","author":"Allen","year":"2023","journal-title":"J Clin Pathol"},{"issue":"40","key":"10.1016\/j.semdp.2025.150948_bib0139","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1080\/14796694.2024.2355078","article-title":"How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancer","volume":"20","author":"Mouawad","year":"2024","journal-title":"Future Oncol"},{"key":"10.1016\/j.semdp.2025.150948_bib0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.humpath.2022.06.009","article-title":"Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications","volume":"132","author":"Luchini","year":"2023","journal-title":"Hum Pathol"},{"issue":"34","key":"10.1016\/j.semdp.2025.150948_bib0141","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.21.01604","article-title":"Overall survival results from the POLO trial: a phase III study of active maintenance Olaparib versus Placebo for Germline BRCA-mutated metastatic pancreatic cancer","volume":"40","author":"Kindler","year":"2022","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.semdp.2025.150948_bib0142","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","article-title":"Genomic methods identify homologous recombination deficiency in Pancreas adenocarcinoma and optimize treatment selection","volume":"26","author":"Park","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.semdp.2025.150948_bib0143","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.semdp.2025.150948_bib0144","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.semdp.2025.150948_bib0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.743908","article-title":"Clinical impact of molecular subtyping of pancreatic cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150948_bib0146","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/0008-5472.CAN-22-3050","article-title":"Spatially resolved single-cell assessment of pancreatic cancer expression subtypes reveals Co-expressor phenotypes and extensive intratumoral heterogeneity","volume":"83","author":"Williams","year":"2023","journal-title":"Cancer Res"},{"issue":"25","key":"10.1016\/j.semdp.2025.150948_bib0147","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","article-title":"Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer","volume":"184","author":"Raghavan","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0148","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/1078-0432.CCR-19-1467","article-title":"Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer","volume":"26","author":"Rashid","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.semdp.2025.150948_bib0149","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-19-3724","article-title":"GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer","volume":"26","author":"O'Kane","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.semdp.2025.150948_bib0150","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1038\/s41467-023-39026-y","article-title":"Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma","volume":"14","author":"Saillard","year":"2023","journal-title":"Nat Commun"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702500084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702500084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:40:55Z","timestamp":1755765655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074025702500084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":150,"alternative-id":["S074025702500084X"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150948","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathological and genetic landscape of pancreatic ductal adenocarcinoma and its variants","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150948"}}